NCT01189461 Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema Status COMPLETED Phase PHASE3
NCT01171976 Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01168258 Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients With and Without Diabetic Macular Edema Status TERMINATED Phase N/A
NCT01141881 Evaluation of the Role of Intravitreal Tissue Plasminogen Activator in Treatment of Refractory Diabetic Macular Edema Status TERMINATED Phase NA
NCT01135914 Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME) Status COMPLETED Phase PHASE3
NCT01120899 A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema Status COMPLETED Phase PHASE1/PHASE2
NCT01112085 MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2) Status COMPLETED Phase PHASE2
NCT01107132 Blood-retinal Barrier Imaging and Neuropsychiatric Sequela in Type 2 Diabetes Mellitus Status UNKNOWN Phase N/A
NCT01077401 Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study Status COMPLETED Phase PHASE2
NCT01045239 Micropulse 577 nm Laser Photocoagulation Versus Conventional 532 nm Laser Photocoagulation for Diabetic Macular Oedema Status UNKNOWN Phase PHASE2
NCT01042678 Study of MP0112 Intravitreal Injection in Patients With Diabetic Macular Edema Status TERMINATED Phase PHASE1
NCT00997191 Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA) Status COMPLETED Phase PHASE3
NCT00994955 Selective Retina Therapy (SRT) for Clinically Significant Diabetic Macular Edema Status COMPLETED Phase PHASE1/PHASE2
NCT00989989 Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema Status COMPLETED Phase PHASE3
NCT00959725 Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema Status UNKNOWN Phase PHASE1/PHASE2
NCT00915837 Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema Status COMPLETED Phase PHASE1
NCT00901186 Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema Status COMPLETED Phase PHASE2
NCT00885794 Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME) Status UNKNOWN Phase PHASE2/PHASE3
NCT00874744 Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema Status COMPLETED Phase PHASE2